Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian J Moran

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics|November 7, 2006
Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantationMichael J Zelefsky, Deborah A Kuban, Larry B Levy, et al.
American Journal of Clinical Oncology|November 22, 2011
ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancerBrian J Moran, Paul DeRose, I-Chow Joe Hsu, et al.
Brachytherapy|April 19, 2011
American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer, Steven J Frank, V Elayne Arterbery, et al.
International Journal of Radiation Oncology, Biology, Physics|November 5, 2015
Definition and Validation of "Favorable High-Risk Prostate Cancer": Implications for Personalizing Treatment of Radiation-Managed PatientsVinayak Muralidhar, Ming-Hui Chen, Gally Reznor, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate sizePaul L Nguyen, Ming H Chen, Toni K Choueiri, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2011
Influence of androgen deprivation therapy on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure or myocardial infarctionPaul L Nguyen, Ming-Hui Chen, Joshua A Beckman, et al.
International Journal of Radiation Oncology, Biology, Physics|August 25, 2014
Establishing high-quality prostate brachytherapy using a phantom simulator training programNikhil G Thaker, Rajat J Kudchadker, David A Swanson, et al.
BJU International|January 14, 2012
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupPeter Grimm, Ignace Billiet, David Bostwick, et al.
BJU International|August 16, 2014
Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancerDavid R Ziehr, Ming-Hui Chen, Danjie Zhang, et al.
Brachytherapy|February 8, 2007
Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United StatesSteven J Frank, Peter D Grimm, John E Sylvester, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
International Journal of Radiation Oncology, Biology, Physics|November 7, 2006
Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantationMichael J Zelefsky, Deborah A Kuban, Larry B Levy, et al.
American Journal of Clinical Oncology|November 22, 2011
ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancerBrian J Moran, Paul DeRose, I-Chow Joe Hsu, et al.
Brachytherapy|April 19, 2011
American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer, Steven J Frank, V Elayne Arterbery, et al.
International Journal of Radiation Oncology, Biology, Physics|November 5, 2015
Definition and Validation of "Favorable High-Risk Prostate Cancer": Implications for Personalizing Treatment of Radiation-Managed PatientsVinayak Muralidhar, Ming-Hui Chen, Gally Reznor, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate sizePaul L Nguyen, Ming H Chen, Toni K Choueiri, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2011
Influence of androgen deprivation therapy on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure or myocardial infarctionPaul L Nguyen, Ming-Hui Chen, Joshua A Beckman, et al.
International Journal of Radiation Oncology, Biology, Physics|August 25, 2014
Establishing high-quality prostate brachytherapy using a phantom simulator training programNikhil G Thaker, Rajat J Kudchadker, David A Swanson, et al.
BJU International|January 14, 2012
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupPeter Grimm, Ignace Billiet, David Bostwick, et al.
BJU International|August 16, 2014
Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancerDavid R Ziehr, Ming-Hui Chen, Danjie Zhang, et al.
Brachytherapy|February 8, 2007
Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United StatesSteven J Frank, Peter D Grimm, John E Sylvester, et al.
Pageof 6